| 引用本文: | 王天煜,于慧,邢中夫,康璇,刘红燕,孙久兰,赵诗阳,赵盼.基于网络药理学和分子对接技术探讨玫瑰花黄酮治疗2型糖尿病的作用机制[J].药学研究,2023,42(7):446-452[点击复制] |
|
| 摘要: |
| 目的 以网络药理学和分子对接技术作为分析方法,探究<玫瑰花黄酮类成分在防治糖尿病中的作用机制。方法 采用TCMSP、GeneCards和DisGeNET数据库获取活性成分和疾病靶点,并绘制Venny图;使用Cytoscape 3.9.0软件制作靶标图;String构建PPI蛋白网络;DAVID进行GO和KEGG富集分析;SYBYL-X2.0和PYMOL进行分子对接验证及展示。结果 玫瑰花黄酮11个活性成分通过调控207个糖尿病相关的疾病靶点,产生了667对活性成分-靶点关系,其中山柰酚、槲皮素、芹菜素等成分通过调控Pathway in cancer、AGE-RAGE、PI3K-Akt等通路防治糖尿病;分子对接显示活性成分与糖尿病核心靶点具有较好的结合活性。 结论 本研究系统揭示了玫瑰花黄酮防治糖尿病“活性成分-靶点”的复杂关系,为玫瑰花治疗2型糖尿病的作用机制提供了理论依据。 |
| 关键词: 玫瑰花 黄酮 网络药理 分子对接 2型糖尿病 |
| DOI:10.13506/j.cnki.jpr.2023.07.003 |
| 基金项目:平阴县特色产业发展项目(No.730134) |
|
出版日期:2023-07-25
|
|
| Study on the mechanism of rose flavonoids in the treatment of type 2 diabetes based on network pharmacology and molecular docking technology |
| WANG Tianyu1,YU Hui1,XING Zhongfu1,KANG Xuan1,LIU Hongyan1,SUN Jiulan2,ZHAO Shiyang2,ZHAO Pan1 |
| (1.Shandong University of Traditional Chinese Medicine, Jinan 250355,China; 2.Characteristic Industry Development Center of Pingyin County, Jinan 250400,China) |
| Abstract: |
| Objective To explore the mechanism of rose flavonoids in the prevention and treatment of diabetes by network pharmacology and Macromolecular docking technology. Methods TCMSP, GeneCards, and DisGeNET databases were used to obtain active ingredients and disease targets, and Venny plots were drawn; Using Cytoscape 3.9.0 software to create target maps; String to construct PPI protein network; DAVID for GO and KEGG enrichment analysis; SYBYL-X2.0 and PYMOL perform Macromolecular docking verification and display. Results Eleven active components of rose flavone produced 667 pairs of active component target relationships by regulating 207 disease targets related to diabetes. Its kaempferol, Quercetin, Apigenin and other components prevented and treated diabetes by regulating Pathway in cancer, AGE-RAGE, PI3K Akt and other pathways; Macromolecular docking showed that the active component had good binding activity to the core target of diabetes. Conclusion This study systematically revealed the complex relationship between the "active ingredient target" of rose flavonoids in the prevention and treatment of diabetes, and provided a theoretical basis for the mechanism of rose in the treatment of type 2 diabetes. |
| Key words: Rose Flavone Network pharmacology Molecular docking Type 2 diabetes |